We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.76B
1-Year Est. Return
62.41%
This Fund
S&P 500
This Quarter
Est. Return
+3.37%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.02B
AUM Growth
-$31.8M
(-0.79%)
Cap. Flow
-$14.7M
Cap. Flow
% of AUM
-0.37%
Top 10 Holdings %
Top 10 Hldgs %
55.91%
Holding
627
New
130
Increased
130
Reduced
70
Closed
208
Avg Time Held Equity + Options
3.7
quarters
Top 10 Avg Time Held Equity + Options
1.3
quarters
Top 20 Avg Time Held Equity + Options
1.5
quarters
Avg Time Held Equity only
3.8
quarters
Top 10 Avg Time Held Equity only
1.3
quarters
Top 20 Avg Time Held Equity only
1.5
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Discover Financial Services
DFS
|
+$191M |
| 2 |
Smartsheet Inc.
SMAR
|
+$188M |
| 3 |
Frontier Communications
FYBR
|
+$124M |
| 4 |
Summit Materials, Inc. Class A Common Stock
SUM
|
+$95M |
| 5 |
Altair Engineering Inc
ALTR
|
+$92.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CATALENT, INC.
CTLT
|
+$234M |
| 2 |
Marathon Oil Corporation
MRO
|
+$222M |
| 3 |
Stericycle Inc
SRCL
|
+$172M |
| 4 |
Axonics, Inc. Common Stock
AXNX
|
+$150M |
| 5 |
Perficient Inc
PRFT
|
+$79.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.76% |
| 2 | Energy | 15.79% |
| 3 | Communication Services | 7.77% |
| 4 | Consumer Staples | 7.72% |
| 5 | Financials | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
376
PUT
Neurocrine Biosciences
NBIX
$14.4B
| $18K | ﹤0.01% |
15,000
-15,000
| -50% | -$1.86M |
2024 Q3
1 quarter
|
|
377
CALL
Corcept Therapeutics
CORT
$13B
| $17.5K | ﹤0.01% |
40,000
-5,000
| -11% | -$262K |
2024 Q3
1 quarter
|
|
378
DELISTED
DigiAsia Corp Warrant
FAASW
| $16.3K | ﹤0.01% |
135,667
| – | – |
2023 Q1
7 quarters
|
|
379
PUT
Novo Nordisk
NVO
$170B
| $15.2K | ﹤0.01% |
10,000
| – | – |
2024 Q3
1 quarter
|
|
380
CALL
Arvinas
ARVN
$492M
| $15K | ﹤0.01% |
40,000
+20,000
| +100% | +$486K |
2024 Q3
1 quarter
|
|
381
CALL
DELISTED
SpringWorks Therapeutics
SWTX
| $13.8K | ﹤0.01% |
+25,000
| New | +$873K |
2024 Q4
0 quarters
|
|
382
Kodiak AI Warrants
KDKRW
| $12.5K | ﹤0.01% |
82,711
| – | – |
2023 Q4
4 quarters
|
|
383
CALL
iShares 7-10 Year Treasury Bond ETF
IEF
$41.3B
| $12.4K | ﹤0.01% |
+75,000
| New | +$7.09M |
2024 Q4
0 quarters
|
|
384
CALL
ARKO Corp
ARKO
$463M
| $12K | ﹤0.01% |
+80,000
| New | +$551K |
2024 Q4
0 quarters
|
|
385
Roadzen Inc Warrants
RDZNW
$5.61M
| $11.2K | ﹤0.01% |
65,696
| – | – |
2022 Q2
10 quarters
|
|
386
Tevogen Inc Warrant
TVGNW
$1.35M
| $11.1K | ﹤0.01% |
181,387
| – | – |
2022 Q1
11 quarters
|
|
387
CALL
Beam Therapeutics
BEAM
$2.63B
| $11K | ﹤0.01% |
+20,000
| New | +$510K |
2024 Q4
0 quarters
|
|
388
CALL
iShares Silver Trust
SLV
$29.3B
| $10.6K | ﹤0.01% |
+708,300
| New | +$20.2M |
2024 Q4
0 quarters
|
|
389
DELISTED
Cartesian Growth Corporation II Warrant
RENEW
| $10.1K | ﹤0.01% |
118,982
| – | – |
2023 Q4
4 quarters
|
|
390
Brand Engagement Network Warrant
BNAIW
$888K
| $9.47K | ﹤0.01% |
150,251
| – | – |
2024 Q1
3 quarters
|
|
391
CALL
Viking Therapeutics
VKTX
$3.61B
| $8.13K | ﹤0.01% |
25,000
+5,000
| +25% | +$285K |
2024 Q1
3 quarters
|
|
392
DELISTED
CSLM Acquisition Corp. Warrant
CSLMW
| $6.39K | ﹤0.01% |
67,295
| – | – |
2023 Q1
7 quarters
|
|
393
MultiSensor AI Holdings Warrant
MSAIW
$715K
| $6.06K | ﹤0.01% |
142,585
| – | – |
2023 Q4
4 quarters
|
|
394
Royalty Management Holding Warrant
RMCOW
$1.01M
| $5.79K | ﹤0.01% |
221,686
| – | – |
2024 Q2
2 quarters
|
|
395
Borealis Foods Inc Warrant
BRLSW
$750K
| $5.42K | ﹤0.01% |
70,030
| – | – |
2024 Q1
3 quarters
|
|
|
BSLKW
396
DELISTED
Bolt Projects Holdings Warrant
BSLKW
| $5.27K | ﹤0.01% |
110,914
| – | – |
2022 Q1
11 quarters
|
|
397
PUT
Bloom Energy
BE
$76.7B
| $5.25K | ﹤0.01% |
+35,000
| New | +$613K |
2024 Q4
0 quarters
|
|
398
CALL
Edgewise Therapeutics
EWTX
$4.21B
| $4.88K | ﹤0.01% |
15,000
-20,000
| -57% | -$637K |
2024 Q3
1 quarter
|
|
399
PUT
Tanger
SKT
$4.04B
| $4.24K | ﹤0.01% |
24,200
| – | – |
2024 Q2
2 quarters
|
|
400
CALL
CRISPR Therapeutics
CRSP
$5B
| $4K | ﹤0.01% |
20,000
-10,000
| -33% | -$472K |
2023 Q4
4 quarters
|
|
Similar funds
FNBT
ACI
RC
A
CGL
CB
JCM
MPM
UBS O'Connor's Q4 2024 Portfolio in Review
As of Q4 2024, UBS O'Connor held 627 positions worth $4.02B, down 0.79% from $4.05B the previous quarter. Its ten largest holdings account for 56% of the portfolio.
UBS O'Connor's Q4 2024 filing shows 130 new, 130 increased, 70 reduced and 208 closed positions. Its largest new stake was Discover Financial Services: 1,166,698 shares worth $202M. The largest sale was CATALENT, INC., an estimated $234M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 20% a quarter earlier, followed by Energy and Communication Services.
- UBS O'Connor's largest Q4 2024 buy was Discover Financial Services: 1,166,698 shares worth $202M.
- UBS O'Connor added most to Smartsheet Inc. in Q4 2024, an estimated $188M increase.
- UBS O'Connor's biggest Q4 2024 reduction was US Steel, cutting an estimated $62.2M.
- UBS O'Connor fully exited CATALENT, INC. in Q4 2024, selling an estimated $234M.
- UBS O'Connor's ten largest holdings make up 56% of its $4.02B portfolio in Q4 2024.
- UBS O'Connor opened 130 new positions and closed 208 in Q4 2024.
- UBS O'Connor's portfolio value fell 0.79% quarter-over-quarter to $4.02B.
Based on UBS O'Connor's 13F filing for Q4 2024, filed 14 Feb 2025.